Aclidinium bromide/formoterol
Подписчиков: 0, рейтинг: 0
| Combination of | |
|---|---|
| Aclidinium bromide | Long-acting muscarinic antagonist |
| Formoterol | Long-acting β2 agonist |
| Clinical data | |
| Trade names | Brimica Genuair, Duaklir Genuair, Duaklir Pressair |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Pregnancy category |
|
| Routes of administration |
Inhalation |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.
External links
- "Aclidinium bromide". Drug Information Portal. U.S. National Library of Medicine.
- "Formoterol fumarate". Drug Information Portal. U.S. National Library of Medicine.
| α1 |
|
||||
|---|---|---|---|---|---|
| α2 |
|
||||
| β |
|
||||
| mAChRs |
|
||||
|---|---|---|---|---|---|
|
Precursors (and prodrugs) |
|||||